Navigation Links
The 'bitter' proteins

A new study says that proteins associated with Alzheimer’s may worsen the symptoms of Parkinson’s disease and vice versa, and understanding this interaction could improve treatments for these conditions, say US researchers. Although both diseases are distinct neurological disorders, up to one-third of Alzheimer’s patients develop Parkinson’s and some Parkinson’s patients develop signs of Alzheimer’s.//

To research a possible link between the two diseases, neurology experts from the University of California and Gladstone developed strains of transgenic mice that produce two human proteins – human amyloid precursor protein (hAPP) and human alpha-synuclein (hSYN).Of the two proteins, hAPP is linked with Alzheimer’s and hSYN with Parkinson’s; and mice that produce one of these proteins develop the symptoms of the associated disease.

The researchers discovered that both Alzheimer’s and Parkinson’s symptoms were worse in the mice that had both conditions than in the mice that had just one of the diseases. Alzheimer-like symptoms – degeneration of particular classes of brain cells and impaired ability to learn – were enhanced by the production of hSYN (the protein associated with Parkinson’s), said the team.

They also found that Abeta – a metabolite of the Alzheimer’s protein hAPP – increased the build-up of hSYN in brain cells. This, said the researchers, shows a possible mechanism for the synergistic effects of one of the proteins on the other.The scientists suggest the interaction between the hAPP and hSYN means that drugs blocking these proteins could have broader benefits than previously thought. The study also helps explain the underlying mechanisms that destroy the cognitive and motor functions of Alzheimer’s patients who go on to develop Parkinson’s, they said.


Page: 1

Related medicine news :

1. Special proteins to fight TB identified
2. Special proteins to fight TB identified
3. Obese children may have abnormalities of lipoproteins
4. Mix and match of proteins may have a significant role in immunity
Post Your Comments:

(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... healthcare professionals worldwide today released the results of a survey of educational needs ... and Africa found a growing global demand for high quality online and face-to-face ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... to announce their strategic partnership at the Radiological Society of North America ... Winscribe, global providers of cutting-edge dictation and speech-enabled documentation software, announced their ...
(Date:11/30/2015)... ... November 30, 2015 , ... Several significant ... coding changes are likely to include new codes for spine and hip X-rays, ... understand the effects of code changes in musculoskeletal, radiology and nervous system sections ...
(Date:11/30/2015)... TX (PRWEB) , ... November 30, 2015 , ... Bayco Products, Inc today announced the ... $11.95 each. Available in a choice of three different colors; red ( NSP-1632 ), yellow ... each run up to 18 hours in constant-on mode, or 27 hours in blinking strobe ...
(Date:11/29/2015)... ... November 30, 2015 , ... Gift ideas ... Sublime Beauty NATURALS®. All products are available on Amazon or its webstore. , ... facial serums and USDA Certified Organic Sesame Oil for Oil Pulling," says Kathy ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... 2015  Hanger, Inc. (NYSE: HGR ) (the ... terms of its previously announced consent solicitation (as amended ... aggregate principal amount 7⅛% Senior Notes due 2018 (the ... fees payable pursuant to the Consent Solicitation, (ii) the ... the expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... LONDON and BOSTON , ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> PFE ) to ... to 10 G protein-coupled receptor (GPCR) targets across multiple ... clinical-stage GPCR structure-guided drug discovery and development company and ...
Breaking Medicine Technology: